What is Alliance for Humane Biotechnology?

 

Genetic modification of plants, animals, and humans is transforming our world and ourselves.  These biotechnological developments, well underway, pose a challenge:  can we create a “humane” biotechnology, one that minimizes conflicts of interest and maximizes transparency, accountability, safety, and social justice?  It starts with you, and Alliance for Humane Biotechnology (AHB) is here to help.   AHB guides you through the political, economic, social, and cultural factors giving rise to human genetic engineering and genetically modified organisms (GMOs).  It clarifies how the processes long converting the natural environment into biological commodities are the same processes now spurring human commodification.  

Check out "AHB 101."  It offers a thumbnail sketch, short videos, and a few readings on the cultural politics of biotechnological development.  Throughout the site, look for AHB NOTES for explanations of terminology, concepts, or technologies.  An AHB QUERY offers a challenge or reflection.

Please bookmark our site.  Tell your Facebook or other social networking friends and colleagues about AHB.  And be sure to visit TAKE ACTION for suggestions on how you can help work for a humane biotechnology.

Welcome!

 
 

About

Find out about our organization, mission, and methods.

Learn More →

Take Action

Ready to take the next step? You can become a contributor or participate yourself.

Take Action →

RECOMMENDED READING:

Available on Amazon    Available from Routledge    Visit on Facebook     Biotech Juggernaut: Hope, Hype, and Hidden Agendas of Entrepreneurial BioScience   (Routledge Books), tells the story of the intensifying effort of bio-entrepreneurs to genetically engineer the human species. The recent gene-editing of twin infant girls in China is only the most recent episode in the decades-long lead up to the era of “designer children.”  Operating under serious conflicts of interest, bioentrepreneur-researchers too often disregard the social consequences of the technologies they develop.  Biotech Juggernaut  recounts biotechnology’s swift advance and describes the hidden social costs of genetically altering human evolution. It concludes with a reflection: Can an informed public halt what appears to be a runaway force?   Advance Praise for Biotech Juggernaut:   “Stevens’ and Newman’s keen insights are grounded both in a long view – putting biotech and its societal implications in broad historical context – and a close-up one, as they recount their personal encounters with the biotech juggernaut in scientific, legal, policy, and advocacy settings. Their stories demonstrate the sweeping commercialization of the biotechnology enterprise, its routine conflicts of interest, and its tendency to exaggerate benefits and minimize hazards. At a time when headlines blare claims of gene-edited babies, their challenge and their guidance are indispensable.”  Marcy Darnovsky , Executive Director of the Center for Genetics and Society  “Tina Stevens and Stuart Newman pull the curtain back on the biotech industrial complex, revealing how its toxic combination of clever marketing and political and financial muscle is perpetuating a branch of science at odds with the public interest.  Biotech Juggernaut  is also the story of how a small group of dedicated activists is fighting back. By the end of this book, you’ll want to join them.”  Jeremy Gruber , Former President of the Council for Responsible Genetics  “Stevens and Newman’s deep familiarity with the events and issues is on clear display in  Biotech Juggernaut . Many books address issues in bioscience, yet fall short of the authors’ rich historical and institutional analysis and their especially illuminating case studies. Even fewer are written with such enlightening critical perspective.”  Elaine Draper , Professor of Sociology, California State University, Los Angeles   “Biotech Juggernaut  is a compelling exposé of high stakes discoveries in genetics with unrealistic expectations pushed prematurely into clinical applications. The authors take on the quintessential hubris of scientists who thumb their nose at evolution, taking it upon themselves, in the face of broad public opposition, to redesign the human genome opening the door to eugenics.”  Sheldon Krimsky , Lenore Stern Professor of Humanities & Social Sciences and Adjunct Professor of Public Health & Community Medicine, Tuft University, and author of  GMOs Decoded

Available on Amazon

Available from Routledge

Visit on Facebook

Biotech Juggernaut: Hope, Hype, and Hidden Agendas of Entrepreneurial BioScience (Routledge Books), tells the story of the intensifying effort of bio-entrepreneurs to genetically engineer the human species. The recent gene-editing of twin infant girls in China is only the most recent episode in the decades-long lead up to the era of “designer children.”

Operating under serious conflicts of interest, bioentrepreneur-researchers too often disregard the social consequences of the technologies they develop. Biotech Juggernaut recounts biotechnology’s swift advance and describes the hidden social costs of genetically altering human evolution. It concludes with a reflection: Can an informed public halt what appears to be a runaway force?

Advance Praise for Biotech Juggernaut:

“Stevens’ and Newman’s keen insights are grounded both in a long view – putting biotech and its societal implications in broad historical context – and a close-up one, as they recount their personal encounters with the biotech juggernaut in scientific, legal, policy, and advocacy settings. Their stories demonstrate the sweeping commercialization of the biotechnology enterprise, its routine conflicts of interest, and its tendency to exaggerate benefits and minimize hazards. At a time when headlines blare claims of gene-edited babies, their challenge and their guidance are indispensable.” Marcy Darnovsky, Executive Director of the Center for Genetics and Society

“Tina Stevens and Stuart Newman pull the curtain back on the biotech industrial complex, revealing how its toxic combination of clever marketing and political and financial muscle is perpetuating a branch of science at odds with the public interest. Biotech Juggernaut is also the story of how a small group of dedicated activists is fighting back. By the end of this book, you’ll want to join them.” Jeremy Gruber, Former President of the Council for Responsible Genetics

“Stevens and Newman’s deep familiarity with the events and issues is on clear display in Biotech Juggernaut. Many books address issues in bioscience, yet fall short of the authors’ rich historical and institutional analysis and their especially illuminating case studies. Even fewer are written with such enlightening critical perspective.” Elaine Draper, Professor of Sociology, California State University, Los Angeles

“Biotech Juggernaut is a compelling exposé of high stakes discoveries in genetics with unrealistic expectations pushed prematurely into clinical applications. The authors take on the quintessential hubris of scientists who thumb their nose at evolution, taking it upon themselves, in the face of broad public opposition, to redesign the human genome opening the door to eugenics.” Sheldon Krimsky, Lenore Stern Professor of Humanities & Social Sciences and Adjunct Professor of Public Health & Community Medicine, Tuft University, and author of GMOs Decoded